| CEO Name | Emily M. Leproust |
| Nationality | France |
| Net Worth Estimation | $60 million |
Emily M. Leproust's estimated net worth of around $60 million primarily derives from her equity holdings and compensation as CEO and co-founder of Twist Bioscience, a publicly traded company specializing in synthetic DNA production. Stock appreciation, performance-based awards, and her sustained leadership role contribute significantly to her overall wealth.
Emily M. Leproust, CEO of Twist Bioscience, has an estimated net worth of $60,000,000, which is 75% of the maximum and 600% of the minimum CEO net worth in the biotechnology sector. Her wealth positions her near the industry's upper echelon for CEO net worth.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
Emily M. Leproust Performance in Twist Bioscience
Emily M. Leproust, CEO of Twist Bioscience, demonstrates visionary leadership and strategic decision-making, driving innovation in synthetic DNA manufacturing. Her performance is marked by successful scaling of the company's technology platform and securing key partnerships, boosting Twist Bioscience's market position and revenue growth. Leproust's impact includes advancing synthetic biology applications and positioning the company as a leader in precision DNA synthesis.
Latest News
Twist Bioscience CEO Emily Leproust Sells Over $1 Million in Shares
Twist Bioscience CEO Emily Leproust recently sold 31,379 shares, reducing her ownership by 4.07% and generating over $986,000 in proceeds, according to SEC filings reported by MarketBeat and GuruFocus. The company continues to focus on innovation in DNA synthesis and strategic growth, with Leproust actively involved in leadership and public presentations.
Source: http://www.marketbeat.com/instant-alerts/twist-bioscience-nasdaqtwst-ceo-emily-leproust-sells-31379-shares-2025-11-03/